Diagnostic Medical Systems S.A. (FRA:DMS1)
Germany · Delayed Price · Currency is EUR 1.270
-0.040 (-3.05%)
At close: Jan 30, 2026
FRA:DMS1 Income Statement
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Operating Revenue | 46.77 | 46.07 | 42.15 | 35.27 | 36.27 | 32.06 |
Other Revenue | 2.7 | 2.79 | 1.96 | 1.79 | 1.76 | 2.97 |
| 49.47 | 48.86 | 44.12 | 37.06 | 38.03 | 35.03 | |
Revenue Growth (YoY) | 9.16% | 10.74% | 19.05% | -2.56% | 8.57% | 2.53% |
Cost of Revenue | 30.71 | 30.32 | 28.1 | 23.02 | 24.32 | 21.61 |
Gross Profit | 18.76 | 18.54 | 16.01 | 14.04 | 13.71 | 13.41 |
Selling, General & Admin | 15.24 | 15.75 | 13.91 | 11.87 | 12.14 | 13.3 |
Amortization of Goodwill & Intangibles | 1.62 | 1.74 | 1.56 | 1.44 | 1.16 | 1.45 |
Other Operating Expenses | 0.42 | 1 | 1.48 | 6.9 | 0.47 | 0.2 |
Operating Expenses | 18.1 | 19.33 | 17.73 | 20.9 | 14.54 | 15.77 |
Operating Income | 0.67 | -0.79 | -1.71 | -6.86 | -0.83 | -2.36 |
Interest Expense | -0.84 | -0.74 | -0.46 | -0.22 | -0.3 | -0.93 |
Currency Exchange Gain (Loss) | 0.07 | 0.12 | -0.19 | 0.01 | 0 | 0.06 |
Other Non Operating Income (Expenses) | -1.3 | -1.65 | -6.93 | -0.55 | -0.13 | -0.02 |
EBT Excluding Unusual Items | -1.4 | -3.05 | -9.28 | -7.62 | -1.26 | -3.24 |
Merger & Restructuring Charges | - | - | -0.8 | - | -1.39 | - |
Impairment of Goodwill | - | - | - | -0.89 | - | - |
Gain (Loss) on Sale of Investments | - | - | - | - | 0.16 | - |
Gain (Loss) on Sale of Assets | 1.13 | 1.13 | - | 2.29 | -0.11 | -1.01 |
Asset Writedown | -0.34 | 0.04 | 0.25 | - | - | - |
Other Unusual Items | -0.72 | -0.72 | - | -0.41 | - | - |
Pretax Income | -1.34 | -2.61 | -9.83 | -6.64 | -2.59 | -4.25 |
Income Tax Expense | 0.19 | 0.21 | 0 | 0.02 | - | -0 |
Earnings From Continuing Operations | -1.53 | -2.82 | -9.84 | -6.66 | -2.59 | -4.25 |
Earnings From Discontinued Operations | - | - | 4.82 | -2.31 | -2.13 | -1.29 |
Net Income to Company | -1.53 | -2.82 | -5.02 | -8.97 | -4.72 | -5.54 |
Minority Interest in Earnings | -0.14 | -0.06 | 0.07 | 2.15 | 0.85 | 0.29 |
Net Income | -1.67 | -2.88 | -4.95 | -6.82 | -3.88 | -5.24 |
Net Income to Common | -1.67 | -2.88 | -4.95 | -6.82 | -3.88 | -5.24 |
Shares Outstanding (Basic) | 23 | 20 | 17 | 16 | 16 | 16 |
Shares Outstanding (Diluted) | 23 | 20 | 17 | 16 | 16 | 16 |
Shares Change (YoY) | 29.76% | 17.09% | 8.33% | - | - | - |
EPS (Basic) | -0.07 | -0.14 | -0.28 | -0.42 | -0.24 | -0.33 |
EPS (Diluted) | -0.07 | -0.14 | -0.28 | -0.42 | -0.24 | -0.33 |
Free Cash Flow | -0.57 | 0.03 | -4.37 | -4.23 | -6.96 | -6.77 |
Free Cash Flow Per Share | -0.03 | 0.00 | -0.25 | -0.26 | -0.43 | -0.42 |
Gross Margin | 37.92% | 37.95% | 36.30% | 37.89% | 36.06% | 38.29% |
Operating Margin | 1.34% | -1.61% | -3.89% | -18.51% | -2.18% | -6.73% |
Profit Margin | -3.37% | -5.90% | -11.21% | -18.40% | -10.19% | -14.96% |
Free Cash Flow Margin | -1.15% | 0.06% | -9.90% | -11.42% | -18.31% | -19.34% |
EBITDA | 2.25 | 1.89 | 0.63 | -3.39 | 1.1 | -1.74 |
EBITDA Margin | 4.55% | 3.87% | 1.42% | -9.15% | 2.90% | -4.97% |
D&A For EBITDA | 1.59 | 2.68 | 2.34 | 3.47 | 1.93 | 0.62 |
EBIT | 0.67 | -0.79 | -1.71 | -6.86 | -0.83 | -2.36 |
EBIT Margin | 1.34% | -1.61% | -3.89% | -18.51% | -2.18% | -6.73% |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.